Non-dairy Yogurt
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Retinal Drugs and Biologics Market Research Report 2024
1 Retinal Drugs and Biologics Market Overview
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Retinal Drugs and Biologics Segment by Type
1.2.1 Global Retinal Drugs and Biologics Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Retinal Drugs and Biologics Segment by Application
1.3.1 Global Retinal Drugs and Biologics Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Retinal Drugs and Biologics Market Size Estimates and Forecasts
1.4.1 Global Retinal Drugs and Biologics Revenue 2017-2028
1.4.2 Global Retinal Drugs and Biologics Sales 2017-2028
1.4.3 Retinal Drugs and Biologics Market Size by Region: 2017 Versus 2021 Versus 2028
2 Retinal Drugs and Biologics Market Competition by Manufacturers
2.1 Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2017-2022)
2.2 Global Retinal Drugs and Biologics Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Retinal Drugs and Biologics Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Retinal Drugs and Biologics Manufacturing Sites, Area Served, Product Type
2.5 Retinal Drugs and Biologics Market Competitive Situation and Trends
2.5.1 Retinal Drugs and Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Retinal Drugs and Biologics Players Market Share by Revenue
2.5.3 Global Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Retinal Drugs and Biologics Retrospective Market Scenario by Region
3.1 Global Retinal Drugs and Biologics Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Retinal Drugs and Biologics Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Retinal Drugs and Biologics Market Facts & Figures by Country
3.3.1 North America Retinal Drugs and Biologics Sales by Country
3.3.2 North America Retinal Drugs and Biologics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Retinal Drugs and Biologics Market Facts & Figures by Country
3.4.1 Europe Retinal Drugs and Biologics Sales by Country
3.4.2 Europe Retinal Drugs and Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Retinal Drugs and Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Retinal Drugs and Biologics Sales by Region
3.5.2 Asia Pacific Retinal Drugs and Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Retinal Drugs and Biologics Market Facts & Figures by Country
3.6.1 Latin America Retinal Drugs and Biologics Sales by Country
3.6.2 Latin America Retinal Drugs and Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Retinal Drugs and Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Retinal Drugs and Biologics Sales by Country
3.7.2 Middle East and Africa Retinal Drugs and Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Retinal Drugs and Biologics Historic Market Analysis by Type
4.1 Global Retinal Drugs and Biologics Sales Market Share by Type (2017-2022)
4.2 Global Retinal Drugs and Biologics Revenue Market Share by Type (2017-2022)
4.3 Global Retinal Drugs and Biologics Price by Type (2017-2022)
5 Global Retinal Drugs and Biologics Historic Market Analysis by Application
5.1 Global Retinal Drugs and Biologics Sales Market Share by Application (2017-2022)
5.2 Global Retinal Drugs and Biologics Revenue Market Share by Application (2017-2022)
5.3 Global Retinal Drugs and Biologics Price by Application (2017-2022)
6 Key Companies Profiled
6.1 ALLERGAN
6.1.1 ALLERGAN Corporation Information
6.1.2 ALLERGAN Description and Business Overview
6.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.1.4 ALLERGAN Retinal Drugs and Biologics Product Portfolio
6.1.5 ALLERGAN Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AbbVie Retinal Drugs and Biologics Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Alimera Sciences
6.3.1 Alimera Sciences Corporation Information
6.3.2 Alimera Sciences Description and Business Overview
6.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Alimera Sciences Retinal Drugs and Biologics Product Portfolio
6.3.5 Alimera Sciences Recent Developments/Updates
6.4 Janssen Biotech
6.4.1 Janssen Biotech Corporation Information
6.4.2 Janssen Biotech Description and Business Overview
6.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Janssen Biotech Retinal Drugs and Biologics Product Portfolio
6.4.5 Janssen Biotech Recent Developments/Updates
6.5 Swedish Orphan Biovitrum
6.5.1 Swedish Orphan Biovitrum Corporation Information
6.5.2 Swedish Orphan Biovitrum Description and Business Overview
6.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Portfolio
6.5.5 Swedish Orphan Biovitrum Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Roche Retinal Drugs and Biologics Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bristol-Myers Squibb Retinal Drugs and Biologics Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Genzyme
6.8.1 Genzyme Corporation Information
6.8.2 Genzyme Description and Business Overview
6.8.3 Genzyme Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Genzyme Retinal Drugs and Biologics Product Portfolio
6.8.5 Genzyme Recent Developments/Updates
6.9 Genentech
6.9.1 Genentech Corporation Information
6.9.2 Genentech Description and Business Overview
6.9.3 Genentech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Genentech Retinal Drugs and Biologics Product Portfolio
6.9.5 Genentech Recent Developments/Updates
6.10 OCULAR THERAPEUTIX
6.10.1 OCULAR THERAPEUTIX Corporation Information
6.10.2 OCULAR THERAPEUTIX Description and Business Overview
6.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Portfolio
6.10.5 OCULAR THERAPEUTIX Recent Developments/Updates
6.11 Bausch & Lomb
6.11.1 Bausch & Lomb Corporation Information
6.11.2 Bausch & Lomb Retinal Drugs and Biologics Description and Business Overview
6.11.3 Bausch & Lomb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Bausch & Lomb Retinal Drugs and Biologics Product Portfolio
6.11.5 Bausch & Lomb Recent Developments/Updates
6.12 UCBCares
6.12.1 UCBCares Corporation Information
6.12.2 UCBCares Retinal Drugs and Biologics Description and Business Overview
6.12.3 UCBCares Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2017-2022)
6.12.4 UCBCares Retinal Drugs and Biologics Product Portfolio
6.12.5 UCBCares Recent Developments/Updates
7 Retinal Drugs and Biologics Manufacturing Cost Analysis
7.1 Retinal Drugs and Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Retinal Drugs and Biologics
7.4 Retinal Drugs and Biologics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Retinal Drugs and Biologics Distributors List
8.3 Retinal Drugs and Biologics Customers
9 Retinal Drugs and Biologics Market Dynamics
9.1 Retinal Drugs and Biologics Industry Trends
9.2 Retinal Drugs and Biologics Market Drivers
9.3 Retinal Drugs and Biologics Market Challenges
9.4 Retinal Drugs and Biologics Market Restraints
10 Global Market Forecast
10.1 Retinal Drugs and Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Retinal Drugs and Biologics by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Retinal Drugs and Biologics by Type (2023-2028)
10.2 Retinal Drugs and Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Retinal Drugs and Biologics by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Retinal Drugs and Biologics by Application (2023-2028)
10.3 Retinal Drugs and Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Retinal Drugs and Biologics by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Retinal Drugs and Biologics by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Retinal Drugs and Biologics Sales Growth Rate Comparison by Type (2022-2028) & (K MT) & (US$ Million)
Table 2. Global Retinal Drugs and Biologics Sales Growth Rate Comparison by Application (2022-2028) & (K MT) & (US$ Million)
Table 3. Global Retinal Drugs and Biologics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Retinal Drugs and Biologics Market Competitive Situation by Manufacturers in 2021
Table 5. Global Retinal Drugs and Biologics Sales (K MT) of Key Manufacturers (2017-2022)
Table 6. Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Retinal Drugs and Biologics Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Retinal Drugs and Biologics Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Retinal Drugs and Biologics Average Price (USD/MT) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Retinal Drugs and Biologics Manufacturing Sites and Area Served
Table 11. Manufacturers Retinal Drugs and Biologics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Retinal Drugs and Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Drugs and Biologics as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Retinal Drugs and Biologics Sales by Region (2017-2022) & (K MT)
Table 16. Global Retinal Drugs and Biologics Sales Market Share by Region (2017-2022)
Table 17. Global Retinal Drugs and Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Retinal Drugs and Biologics Revenue Market Share by Region (2017-2022)
Table 19. North America Retinal Drugs and Biologics Sales by Country (2017-2022) & (K MT)
Table 20. North America Retinal Drugs and Biologics Sales Market Share by Country (2017-2022)
Table 21. North America Retinal Drugs and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Retinal Drugs and Biologics Revenue Market Share by Country (2017-2022)
Table 23. Europe Retinal Drugs and Biologics Sales by Country (2017-2022) & (K MT)
Table 24. Europe Retinal Drugs and Biologics Sales Market Share by Country (2017-2022)
Table 25. Europe Retinal Drugs and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Retinal Drugs and Biologics Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Retinal Drugs and Biologics Sales by Region (2017-2022) & (K MT)
Table 28. Asia Pacific Retinal Drugs and Biologics Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Retinal Drugs and Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Retinal Drugs and Biologics Revenue Market Share by Region (2017-2022)
Table 31. Latin America Retinal Drugs and Biologics Sales by Country (2017-2022) & (K MT)
Table 32. Latin America Retinal Drugs and Biologics Sales Market Share by Country (2017-2022)
Table 33. Latin America Retinal Drugs and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Retinal Drugs and Biologics Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Retinal Drugs and Biologics Sales by Country (2017-2022) & (K MT)
Table 36. Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Retinal Drugs and Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Retinal Drugs and Biologics Revenue Market Share by Country (2017-2022)
Table 39. Global Retinal Drugs and Biologics Sales by Type (2017-2022) & (K MT)
Table 40. Global Retinal Drugs and Biologics Sales Market Share by Type (2017-2022)
Table 41. Global Retinal Drugs and Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Retinal Drugs and Biologics Revenue Share by Type (2017-2022)
Table 43. Global Retinal Drugs and Biologics Price by Type (2017-2022) & (USD/MT)
Table 44. Global Retinal Drugs and Biologics Sales (K MT) by Application (2017-2022)
Table 45. Global Retinal Drugs and Biologics Sales Market Share by Application (2017-2022)
Table 46. Global Retinal Drugs and Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Retinal Drugs and Biologics Revenue Share by Application (2017-2022)
Table 48. Global Retinal Drugs and Biologics Price by Application (2017-2022) & (USD/MT)
Table 49. ALLERGAN Corporation Information
Table 50. ALLERGAN Description and Business Overview
Table 51. ALLERGAN Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 52. ALLERGAN Retinal Drugs and Biologics Product
Table 53. ALLERGAN Recent Developments/Updates
Table 54. AbbVie Corporation Information
Table 55. AbbVie Description and Business Overview
Table 56. AbbVie Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 57. AbbVie Retinal Drugs and Biologics Product
Table 58. AbbVie Recent Developments/Updates
Table 59. Alimera Sciences Corporation Information
Table 60. Alimera Sciences Description and Business Overview
Table 61. Alimera Sciences Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 62. Alimera Sciences Retinal Drugs and Biologics Product
Table 63. Alimera Sciences Recent Developments/Updates
Table 64. Janssen Biotech Corporation Information
Table 65. Janssen Biotech Description and Business Overview
Table 66. Janssen Biotech Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 67. Janssen Biotech Retinal Drugs and Biologics Product
Table 68. Janssen Biotech Recent Developments/Updates
Table 69. Swedish Orphan Biovitrum Corporation Information
Table 70. Swedish Orphan Biovitrum Description and Business Overview
Table 71. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 72. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product
Table 73. Swedish Orphan Biovitrum Recent Developments/Updates
Table 74. Roche Corporation Information
Table 75. Roche Description and Business Overview
Table 76. Roche Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 77. Roche Retinal Drugs and Biologics Product
Table 78. Roche Recent Developments/Updates
Table 79. Bristol-Myers Squibb Corporation Information
Table 80. Bristol-Myers Squibb Description and Business Overview
Table 81. Bristol-Myers Squibb Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 82. Bristol-Myers Squibb Retinal Drugs and Biologics Product
Table 83. Bristol-Myers Squibb Recent Developments/Updates
Table 84. Genzyme Corporation Information
Table 85. Genzyme Description and Business Overview
Table 86. Genzyme Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 87. Genzyme Retinal Drugs and Biologics Product
Table 88. Genzyme Recent Developments/Updates
Table 89. Genentech Corporation Information
Table 90. Genentech Description and Business Overview
Table 91. Genentech Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 92. Genentech Retinal Drugs and Biologics Product
Table 93. Genentech Recent Developments/Updates
Table 94. OCULAR THERAPEUTIX Corporation Information
Table 95. OCULAR THERAPEUTIX Description and Business Overview
Table 96. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 97. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product
Table 98. OCULAR THERAPEUTIX Recent Developments/Updates
Table 99. Bausch & Lomb Corporation Information
Table 100. Bausch & Lomb Description and Business Overview
Table 101. Bausch & Lomb Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 102. Bausch & Lomb Retinal Drugs and Biologics Product
Table 103. Bausch & Lomb Recent Developments/Updates
Table 104. UCBCares Corporation Information
Table 105. UCBCares Description and Business Overview
Table 106. UCBCares Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 107. UCBCares Retinal Drugs and Biologics Product
Table 108. UCBCares Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Retinal Drugs and Biologics Distributors List
Table 112. Retinal Drugs and Biologics Customers List
Table 113. Retinal Drugs and Biologics Market Trends
Table 114. Retinal Drugs and Biologics Market Drivers
Table 115. Retinal Drugs and Biologics Market Challenges
Table 116. Retinal Drugs and Biologics Market Restraints
Table 117. Global Retinal Drugs and Biologics Sales Forecast by Type (2023-2028) & (K MT)
Table 118. Global Retinal Drugs and Biologics Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Retinal Drugs and Biologics Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Retinal Drugs and Biologics Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Retinal Drugs and Biologics Sales Forecast by Application (2023-2028) & (K MT)
Table 122. Global Retinal Drugs and Biologics Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Retinal Drugs and Biologics Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Retinal Drugs and Biologics Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Retinal Drugs and Biologics Sales Forecast by Region (2023-2028) & (K MT)
Table 126. Global Retinal Drugs and Biologics Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Retinal Drugs and Biologics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Retinal Drugs and Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Retinal Drugs and Biologics
Figure 2. Global Retinal Drugs and Biologics Market Share by Type in 2021 & 2028
Figure 3. Age Related Macular Degeneration Product Picture
Figure 4. Diabetic Retinopathy Product Picture
Figure 5. Ocular Inflammatory Disease (Uveitis) Product Picture
Figure 6. Macular Hole Product Picture
Figure 7. Global Retinal Drugs and Biologics Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Retinal Drugs and Biologics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Retinal Drugs and Biologics Market Size (2017-2028) & (US$ Million)
Figure 13. Global Retinal Drugs and Biologics Sales (2017-2028) & (K MT)
Figure 14. Retinal Drugs and Biologics Sales Share by Manufacturers in 2021
Figure 15. Global Retinal Drugs and Biologics Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Retinal Drugs and Biologics Players: Market Share by Revenue in 2021
Figure 17. Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Retinal Drugs and Biologics Sales Market Share by Region (2017-2022)
Figure 19. Global Retinal Drugs and Biologics Sales Market Share by Region in 2021
Figure 20. Global Retinal Drugs and Biologics Revenue Market Share by Region (2017-2022)
Figure 21. Global Retinal Drugs and Biologics Revenue Market Share by Region in 2021
Figure 22. U.S. Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Retinal Drugs and Biologics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Retinal Drugs and Biologics by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Retinal Drugs and Biologics
Figure 48. Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure 49. Retinal Drugs and Biologics Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ALLERGAN AbbVie Alimera Sciences Janssen Biotech Swedish Orphan Biovitrum Roche Bristol-Myers Squibb Genzyme Genentech OCULAR THERAPEUTIX Bausch & Lomb UCBCares